Profile picture

Professor Aylin Yildirir

Baskent University, Ankara (Turkiye)
Membership: ESC Professional Member
Follow
Biography
Education 1986-1993 HacettepeUniversity Faculty of Medicine (English Group) 1993-1998 Hacettepe University Faculty of Medicine, Cardiology Work Experience: 1998-2001 Instructor, Hacettepe University, Cardiology 2001-2002 Instructor, Başkent University, Cardiology 2002-2003 Asistant Professor, Başkent University, Cardiology 2003-2009 Associate Professor, Başkent University, Cardiology 2009- Professor, Başkent University, Cardiology Journal Editing, Advisory Board Memberships: Archives of Turkish Society of Cardiology (Board Member) Anatolian Journal of Cardiology (Deputy Editor) Professional Memberships Turkish Society of Cardiology European Society of Cardiology (Fellow) American Collage of Cardiology (Fellow) European Association of Percutaneous Cardiovascular Interventions Turkish Board of Cardiology (Vise President) Guideline Committee of TSC (President) National Coordinator of ESC Guidelines on behalf of Turkish Society of Cardiology
Logo ESC

Contributor content

Innovations in post-infarction care: cardiometabolic, molecular, and haemodynamic approaches
Session
Innovations in post-infarction care: cardiometabolic, molecular, and haemodynamic approaches
30 August 2026
Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition
Session
Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition
28 August 2026
Beyond myocardial ischaemia: different aspects of pharmacotherapy and revascularisation
Session
Beyond myocardial ischaemia: different aspects of pharmacotherapy and revascularisation
28 August 2026
Risk prediction in non-cardiac surgery
Session
Risk prediction in non-cardiac surgery
1 September 2025
Rule in/out of acute coronary syndromes in the emergency setting
Session
Rule in/out of acute coronary syndromes in the emergency setting
26 August 2023
Safety issues with anti-platelets drugs
Session
Safety issues with anti-platelets drugs
26 August 2018